Efficacy and safety of empagliflozin in GSD type Ib: data from an international questionnaire survey | Webinar Recording10th May 2022 DescriptionA paediatric metabolic specialist presents international data on the growing use of empagliflozin to manage neutropenia in GSD type Ib.
AuthorRecordedOTHER RESOURCES YOU MAY BE INTERESTED INWE HAVE A WEALTH OF RESOURCES FOR |